MedTrace Logo

Cardiometabolic Status in Childhood Acute Lymphoblastic Leukemia

NCT01688752 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2014-08-22

No results posted yet for this study

Summary

This is a prospective cohort study assessing measures of cardiometabolic status, body composition, IR and GH response to stimulation after therapy in children (age 7-21 years) treated for ALL. Patients and sibling controls will be recruited from the Pediatric Hematology-Oncology Clinic at the University of Minnesota Amplatz Children's Hospital.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Julia Steinberger, MD, MS · Masonic Cancer Center, University of Minnesota

Eligibility

Min Age
7 Years
Max Age
21 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01688752 on ClinicalTrials.gov